Many of these reports attribute I3C-mediated protective effects to the ability of this compound to activate AhR, which was illustrated in one of the earliest studies showing I3C’s protective effects against DSS-induced colitis were negated in AhR-null mice (65). This evidence concerns the gene AHR and colitis.